In this study, we investigated the glucose metabolism-related gene set in ccRCC and its prognostic value and developed a prognostic risk signature based on six glucose metabolism-related genes (FBP1, GYG2, KAT2A, LGALS1, PFKP, and RGN). This evidence concerns the gene KAT2A and nonpapillary renal cell carcinoma.